GB2262886B - N-channel calcium antagonists useful for treating bronchial diseases - Google Patents

N-channel calcium antagonists useful for treating bronchial diseases

Info

Publication number
GB2262886B
GB2262886B GB9126739A GB9126739A GB2262886B GB 2262886 B GB2262886 B GB 2262886B GB 9126739 A GB9126739 A GB 9126739A GB 9126739 A GB9126739 A GB 9126739A GB 2262886 B GB2262886 B GB 2262886B
Authority
GB
United Kingdom
Prior art keywords
calcium antagonists
antagonists useful
treating bronchial
bronchial diseases
channel calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9126739A
Other versions
GB2262886A (en
GB9126739D0 (en
Inventor
Ann Bond
John Robert Boot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Priority to GB9126739A priority Critical patent/GB2262886B/en
Publication of GB9126739D0 publication Critical patent/GB9126739D0/en
Publication of GB2262886A publication Critical patent/GB2262886A/en
Application granted granted Critical
Publication of GB2262886B publication Critical patent/GB2262886B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9126739A 1991-12-17 1991-12-17 N-channel calcium antagonists useful for treating bronchial diseases Expired - Fee Related GB2262886B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9126739A GB2262886B (en) 1991-12-17 1991-12-17 N-channel calcium antagonists useful for treating bronchial diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9126739A GB2262886B (en) 1991-12-17 1991-12-17 N-channel calcium antagonists useful for treating bronchial diseases

Publications (3)

Publication Number Publication Date
GB9126739D0 GB9126739D0 (en) 1992-02-12
GB2262886A GB2262886A (en) 1993-07-07
GB2262886B true GB2262886B (en) 1995-09-06

Family

ID=10706385

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9126739A Expired - Fee Related GB2262886B (en) 1991-12-17 1991-12-17 N-channel calcium antagonists useful for treating bronchial diseases

Country Status (1)

Country Link
GB (1) GB2262886B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU735724B2 (en) * 1996-11-18 2001-07-12 University Of Utah Research Foundation Use of conotoxin peptides ImI and MII as cardiovascular agents
WO2005000285A2 (en) * 2003-06-13 2005-01-06 Dynogen Pharmaceuticals, Inc. METHODS OF TREATING NON-INFLAMMATORY GASTROINTESTINAL TRACT DISORDERS USING Cav2.2 SUBUNIT CALCIUM CHANNEL MODULATORS

Also Published As

Publication number Publication date
GB2262886A (en) 1993-07-07
GB9126739D0 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
IL108772A0 (en) Treatment of rhinitis by biostimulative illumination
GB2261821B (en) Orthopaedic aid
EP0814814A4 (en) Methods for the treatment of thrombosis
HU910312D0 (en) Preparation for treating human nails
ZA93550B (en) Azabricyclic compounds as calcium channel antagonists
GB9221395D0 (en) Applicance for indoor gymnastics
HU9501923D0 (en) Substituted azolone derivatives for treating diseases caused by helicobacter
AP9200453A0 (en) Medicaments for treating inflammatory conditions or for analgiesia
EP0510503A3 (en) Process for the treatment of surfaces
AP9200428A0 (en) Compounds for treating leukotriene-related diseases
GB9116499D0 (en) Treatment method for zeolites
GB9219421D0 (en) Treating waste
FI961378A0 (en) Process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl) -14-indole-5-ethanesulfonamide
NZ235610A (en) Treating bone diseases with bafilomycin-type compounds
EP0741568A4 (en) Inhibition of arthritis by l-type calcium channel antagonists
GB2262886B (en) N-channel calcium antagonists useful for treating bronchial diseases
ZA891894B (en) Composition for the treatment of osteoporosis in humans
ZA928198B (en) Substituted azaspiranes for use in the treatment of hyperlipidemia
HU9501779D0 (en) Agents for treating metabolic bone diseases
GB9217547D0 (en) Leather treatment compositions
ZA943115B (en) Treatment for toxoplasmosis
GB9317943D0 (en) Treatment of laminitis
ZA926245B (en) Cholecystokinin antagonists useful for treating depression
ZA927160B (en) Compounds for treating leukotriene-related diseases.
GB9317989D0 (en) Treatment of laminitis

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19971217